1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2 MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET BY ACNE TYPE
2.1 OVERVIEW
2.2 INFLAMMATORY ACNE MARKET
2.3 NON-INFLAMMATORY ACNE MARKET
3 MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET BY FORMULATION
3.1 OVERVIEW
3.2 TOPICAL MEDICATIONS MARKET
3.3 ORAL MEDICATIONS MARKET
4 MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET BY THERAPEUTIC CLASS
4.1 OVERVIEW
4.2 RETINOIDS MARKET
4.3 ANTIBIOTICS MARKET
4.4 SALICYLIC ACID MARKET
4.5 BENZOYL PEROXIDE MARKET
4.6 OTHERS MARKET
5 MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET BY DISTRIBUTION CHANNEL
5.1 OVERVIEW
5.2 MED SPA MARKET
5.3 AESTHETICIAN MARKET
5.4 DERMATOLOGIST MARKET
5.5 OTHER PROFESSIONAL CHANNELS MARKET
6 COMPANY PROFILES
6.1 ALMIRALL SA
6.1.1 COMPANY OVERVIEW
6.1.2 COMPANY SNAPSHOT
6.1.3 OPERATING BUSINESS SEGMENTS
6.1.4 PRODUCT PORTFOLIO
6.1.5 BUSINESS PERFORMANCE
6.1.6 BUSINESS SEGMENTS
6.1.7 GEOGRAPHIC SEGMENTS
6.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.1.9 PRIMARY MARKET COMPETITORS
6.2 BAUSCH HEALTH COMPANIES, INC.
6.2.1 COMPANY OVERVIEW
6.2.2 COMPANY SNAPSHOT
6.2.3 OPERATING BUSINESS SEGMENTS
6.2.4 PRODUCT PORTFOLIO
6.2.5 BUSINESS PERFORMANCE
6.2.6 BUSINESS SEGMENTS
6.2.7 GEOGRAPHIC SEGMENTS
6.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.2.9 PRIMARY MARKET COMPETITORS
6.3 GLAXOSMITHKLINE PLC (GSK)
6.3.1 COMPANY OVERVIEW
6.3.2 COMPANY SNAPSHOT
6.3.3 OPERATING BUSINESS SEGMENTS
6.3.4 PRODUCT PORTFOLIO
6.3.5 BUSINESS PERFORMANCE
6.3.6 BUSINESS SEGMENTS
6.3.7 GEOGRAPHIC SEGMENTS
6.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.3.9 PRIMARY MARKET COMPETITORS
6.4 GALDERMA S.A.
6.4.1 COMPANY OVERVIEW
6.4.2 COMPANY SNAPSHOT
6.4.3 OPERATING BUSINESS SEGMENTS
6.4.4 PRODUCT PORTFOLIO
6.4.5 BUSINESS PERFORMANCE
6.4.6 BUSINESS SEGMENTS
6.4.7 GEOGRAPHIC SEGMENTS
6.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.4.9 PRIMARY MARKET COMPETITORS
6.5 SUN PHARMACEUTICAL INDUSTRIES LIMITED
6.5.1 COMPANY OVERVIEW
6.5.2 COMPANY SNAPSHOT
6.5.3 OPERATING BUSINESS SEGMENTS
6.5.4 PRODUCT PORTFOLIO
6.5.5 BUSINESS PERFORMANCE
6.5.6 BUSINESS SEGMENTS
6.5.7 GEOGRAPHIC SEGMENTS
6.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.5.9 PRIMARY MARKET COMPETITORS
6.6 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.6.1 COMPANY OVERVIEW
6.6.2 COMPANY SNAPSHOT
6.6.3 OPERATING BUSINESS SEGMENTS
6.6.4 PRODUCT PORTFOLIO
6.6.5 BUSINESS PERFORMANCE
6.6.6 BUSINESS SEGMENTS
6.6.7 GEOGRAPHIC SEGMENTS
6.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.6.9 PRIMARY MARKET COMPETITORS
6.7 JOHNSON AND JOHNSON
6.7.1 COMPANY OVERVIEW
6.7.2 COMPANY SNAPSHOT
6.7.3 OPERATING BUSINESS SEGMENTS
6.7.4 PRODUCT PORTFOLIO
6.7.5 BUSINESS PERFORMANCE
6.7.6 BUSINESS SEGMENTS
6.7.7 GEOGRAPHIC SEGMENTS
6.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.7.9 PRIMARY MARKET COMPETITORS
6.8 STRATA SKIN SCIENCES, INC.
6.8.1 COMPANY OVERVIEW
6.8.2 COMPANY SNAPSHOT
6.8.3 OPERATING BUSINESS SEGMENTS
6.8.4 PRODUCT PORTFOLIO
6.8.5 BUSINESS PERFORMANCE
6.8.6 BUSINESS SEGMENTS
6.8.7 GEOGRAPHIC SEGMENTS
6.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.8.9 PRIMARY MARKET COMPETITORS
6.9 MAYNE PHARMA GROUP LIMITED
6.9.1 COMPANY OVERVIEW
6.9.2 COMPANY SNAPSHOT
6.9.3 OPERATING BUSINESS SEGMENTS
6.9.4 PRODUCT PORTFOLIO
6.9.5 BUSINESS PERFORMANCE
6.9.6 BUSINESS SEGMENTS
6.9.7 GEOGRAPHIC SEGMENTS
6.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.9.9 PRIMARY MARKET COMPETITORS
6.10 PFIZER, INC.
6.10.1 COMPANY OVERVIEW
6.10.2 COMPANY SNAPSHOT
6.10.3 OPERATING BUSINESS SEGMENTS
6.10.4 PRODUCT PORTFOLIO
6.10.5 BUSINESS PERFORMANCE
6.10.6 BUSINESS SEGMENTS
6.10.7 GEOGRAPHIC SEGMENTS
6.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.10.9 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 2. INFLAMMATORY ACNE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 3. NON-INFLAMMATORY ACNE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 4. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 5. TOPICAL MEDICATIONS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 6. ORAL MEDICATIONS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 7. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 8. RETINOIDS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 9. ANTIBIOTICS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 10. SALICYLIC ACID, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 11. BENZOYL PEROXIDE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 12. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 13. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 14. MED SPA, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 15. AESTHETICIAN, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 16. DERMATOLOGIST, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 17. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 18. ALMIRALL SA: COMPANY SNAPSHOT
TABLE 19. ALMIRALL SA: OPERATING BUSINESS SEGMENTS
TABLE 20. ALMIRALL SA: PRODUCT PORTFOLIO
TABLE 21. ALMIRALL SA: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 22. ALMIRALL SA: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 23. ALMIRALL SA: KEY STRATERGY
TABLE 24. BAUSCH HEALTH COMPANIES, INC.: COMPANY SNAPSHOT
TABLE 25. BAUSCH HEALTH COMPANIES, INC.: OPERATING BUSINESS SEGMENTS
TABLE 26. BAUSCH HEALTH COMPANIES, INC.: PRODUCT PORTFOLIO
TABLE 27. BAUSCH HEALTH COMPANIES, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 28. BAUSCH HEALTH COMPANIES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 29. BAUSCH HEALTH COMPANIES, INC.: KEY STRATERGY
TABLE 30. GLAXOSMITHKLINE PLC (GSK): COMPANY SNAPSHOT
TABLE 31. GLAXOSMITHKLINE PLC (GSK): OPERATING BUSINESS SEGMENTS
TABLE 32. GLAXOSMITHKLINE PLC (GSK): PRODUCT PORTFOLIO
TABLE 33. GLAXOSMITHKLINE PLC (GSK): SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 34. GLAXOSMITHKLINE PLC (GSK): SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 35. GLAXOSMITHKLINE PLC (GSK): KEY STRATERGY
TABLE 36. GALDERMA S.A.: COMPANY SNAPSHOT
TABLE 37. GALDERMA S.A.: OPERATING BUSINESS SEGMENTS
TABLE 38. GALDERMA S.A.: PRODUCT PORTFOLIO
TABLE 39. GALDERMA S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 40. GALDERMA S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 41. GALDERMA S.A.: KEY STRATERGY
TABLE 42. SUN PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT
TABLE 43. SUN PHARMACEUTICAL INDUSTRIES LIMITED: OPERATING BUSINESS SEGMENTS
TABLE 44. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO
TABLE 45. SUN PHARMACEUTICAL INDUSTRIES LIMITED: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 46. SUN PHARMACEUTICAL INDUSTRIES LIMITED: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 47. SUN PHARMACEUTICAL INDUSTRIES LIMITED: KEY STRATERGY
TABLE 48. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 49. TEVA PHARMACEUTICAL INDUSTRIES LTD.: OPERATING BUSINESS SEGMENTS
TABLE 50. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 51. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 52. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 53. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATERGY
TABLE 54. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 55. JOHNSON AND JOHNSON: OPERATING BUSINESS SEGMENTS
TABLE 56. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 57. JOHNSON AND JOHNSON: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 58. JOHNSON AND JOHNSON: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 59. JOHNSON AND JOHNSON: KEY STRATERGY
TABLE 60. STRATA SKIN SCIENCES, INC.: COMPANY SNAPSHOT
TABLE 61. STRATA SKIN SCIENCES, INC.: OPERATING BUSINESS SEGMENTS
TABLE 62. STRATA SKIN SCIENCES, INC.: PRODUCT PORTFOLIO
TABLE 63. STRATA SKIN SCIENCES, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 64. STRATA SKIN SCIENCES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 65. STRATA SKIN SCIENCES, INC.: KEY STRATERGY
TABLE 66. MAYNE PHARMA GROUP LIMITED: COMPANY SNAPSHOT
TABLE 67. MAYNE PHARMA GROUP LIMITED: OPERATING BUSINESS SEGMENTS
TABLE 68. MAYNE PHARMA GROUP LIMITED: PRODUCT PORTFOLIO
TABLE 69. MAYNE PHARMA GROUP LIMITED: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 70. MAYNE PHARMA GROUP LIMITED: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 71. MAYNE PHARMA GROUP LIMITED: KEY STRATERGY
TABLE 72. PFIZER, INC.: COMPANY SNAPSHOT
TABLE 73. PFIZER, INC.: OPERATING BUSINESS SEGMENTS
TABLE 74. PFIZER, INC.: PRODUCT PORTFOLIO
TABLE 75. PFIZER, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 76. PFIZER, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 77. PFIZER, INC.: KEY STRATERGY
LIST OF FIGURES
FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
FIGURE 7. INFLAMMATORY ACNE , MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 8. NON-INFLAMMATORY ACNE, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 9. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
FIGURE 10. TOPICAL MEDICATIONS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 11. ORAL MEDICATIONS , MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 12. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
FIGURE 13. RETINOIDS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 14. ANTIBIOTICS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 15. SALICYLIC ACID, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 16. BENZOYL PEROXIDE, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 17. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 18. MIDDLE EAST PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
FIGURE 19. MED SPA, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 20. AESTHETICIAN, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 21. DERMATOLOGIST, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 22. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 23. ALMIRALL SA: NET SALES, (2021-2023)
FIGURE 24. ALMIRALL SA: PRIMARY MARKET COMPETITORS
FIGURE 25. BAUSCH HEALTH COMPANIES, INC.: NET SALES, (2021-2023)
FIGURE 26. BAUSCH HEALTH COMPANIES, INC.: PRIMARY MARKET COMPETITORS
FIGURE 27. GLAXOSMITHKLINE PLC (GSK): NET SALES, (2021-2023)
FIGURE 28. GLAXOSMITHKLINE PLC (GSK): PRIMARY MARKET COMPETITORS
FIGURE 29. GALDERMA S.A.: NET SALES, (2021-2023)
FIGURE 30. GALDERMA S.A.: PRIMARY MARKET COMPETITORS
FIGURE 31. SUN PHARMACEUTICAL INDUSTRIES LIMITED: NET SALES, (2021-2023)
FIGURE 32. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRIMARY MARKET COMPETITORS
FIGURE 33. TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET SALES, (2021-2023)
FIGURE 34. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRIMARY MARKET COMPETITORS
FIGURE 35. JOHNSON AND JOHNSON: NET SALES, (2021-2023)
FIGURE 36. JOHNSON AND JOHNSON: PRIMARY MARKET COMPETITORS
FIGURE 37. STRATA SKIN SCIENCES, INC.: NET SALES, (2021-2023)
FIGURE 38. STRATA SKIN SCIENCES, INC.: PRIMARY MARKET COMPETITORS
FIGURE 39. MAYNE PHARMA GROUP LIMITED: NET SALES, (2021-2023)
FIGURE 40. MAYNE PHARMA GROUP LIMITED: PRIMARY MARKET COMPETITORS
FIGURE 41. PFIZER, INC.: NET SALES, (2021-2023)
FIGURE 42. PFIZER, INC.: PRIMARY MARKET COMPETITOR